TENX
TENX
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$1.46M
Insider Sales
0
$0
Total Volume
$1.46M
11 transactions
Net Activity
+$1.46M
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •High accumulation: total purchase value exceeds $1M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$22059.32B total
Adar1 Capital Management, LLC
10%
$1.46M total
Quick Actions
TENX has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at TENX (TENX) engaged in a total of 11 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $1.46M.
The net insider activity for TENX shows a net buying bias of $1.46M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 7.45M shares valued at $6872.46B on Oct 19, 2026.
Wall Street Analysts Predict a 121.36% Upside in Tenax Therapeutics (TENX): Here's What You Should Know
TENX - Tenax Therapeutics Inc Stock Price and Quote
Robbins LLP Urges TENX Investors to Contact the Firm to
TENX Stock Drifts Lower As Traders Watch Tight Range
TENX UPCOMING DEADLINE: Levi & Korsinsky Alerts Tenax Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
Tenax Therapeutics Stock (TENX) Opinions on Recent Insider Purchases and Gains
FAQs About TENX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for TENX.